|
|
|
Volumn 16, Issue 6, 1995, Pages 755-758
|
|
Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation
a
|
|
Author keywords
GVHD; Methotrexate; Sibling BMT; Survival
|
|
Indexed keywords
BUSULFAN;
COTRIMOXAZOLE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
GANCICLOVIR;
METHOTREXATE;
ADOLESCENT;
ADULT;
ARTICLE;
BONE MARROW TRANSPLANTATION;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC DISEASE;
HLA MATCHING;
HUMAN;
HUMAN TISSUE;
INCIDENCE;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MUCOSA INFLAMMATION;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RECURRENCE RISK;
SIBLING;
SURVIVAL;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
BONE MARROW TRANSPLANTATION;
CHRONIC DISEASE;
FEMALE;
GRAFT VS HOST DISEASE;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
METHOTREXATE;
MIDDLE AGED;
RECURRENCE;
SURVIVAL ANALYSIS;
|
|
EID: 0029585935
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (20)
|
|
References (0)
|
